NEWS FEED & ADDITIVE MAGAZINE October 2023 13 Novozymes and Bactolife join forces for health of piglets Novozymes and the Danish industrial biotech company, Bactolife, signed a joint development and commercialization agreement to finish development and launch the biosolution Ablacto+. The promising product can potentially stabilize the gut of piglets and reduce the severity of post weaning diarrhea (PWD). PWD is a major, global swine health challenge caused by E. coli infections in newly weaned pigs. Globally, PWD is estimated to lead to a loss of production of EUR 1-2 billion per year. Additionally, PWD is considered the main driver for antibiotic use in weaner pigs. “Post weaning diarrhea is one of the biggest challenges in the global swine industry. We are very excited to join this partnership with Bactolife. Together, we will be able to develop innovative biosolutions that can stabilize the gut of piglets, increase productivity, and significantly reduce the use of antibiotic use among pigs,” says Sofie Louise Trads, Director, Animal Health at Novozymes. “We are extremely happy to partner with Novozymes on this promising product. This is a major validation of Bactolife’s technology platform, and with a strong commercial partnership in the Animal Health space like Novozymes, we believe there is a significant business potential for both parties,” says Sebastian Søderberg, CEO at Bactolife. According to the company's statement, the product candidate, Ablacto+, is a functional feed additive which consists of binding proteins with a specific mode of action. Read more>> Supplant D MCFA blend for gut health support • Large antimicrobial spectrum • Supports the immune function by limiting white cell apoptosis • Better nutrient absorption through increase gut surface agrimprove.com Aromabiotic®
RkJQdWJsaXNoZXIy MTUxNjkxNQ==